BioSpace News Archive

Biotech Bay

Three Arch’s shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures

The Three Arch funds that held the AcelRx shares were each formed between 1999 and 2004 and are at the end of their respective terms.

May 23, 2018

·

4 min read

Drug Development

Motus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized Patients

Published studies show insufficient bowel prep can occur in over 55% of inpatient cases and lead to average of 2 day hospital stay extension and as much as $8,000 in additional costs

May 23, 2018

·

5 min read

IOTA Pharmaceuticals Announce the Creation of a Glioblastoma Drug Bank to Support and Accelerate New Research Into Brain Cancer Therapy

IOTA Pharmaceuticals Ltd today announced the creation of a new resource, the Glioblastoma (GBM) Drug Bank, to accelerate drug discovery research in brain cancer, especially glioblastoma.

May 23, 2018

·

2 min read

Eyecarrot Announces Shipment of its First 50 Binovi Touch Saccadic Fixator Units

After extensive development work, the release of the first 50 units represents a major milestone for the company

May 23, 2018

·

4 min read

BioCapital

HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic Travel

HETLIOZ® demonstrates significant improvement in objective and subjective measures of Jet Lag during 5 hour and 8 hour time zone transatlantic travel from the US to the UK

May 23, 2018

·

10 min read

Biotech Bay

Broncus Medical Announces New Study That Shows High Diagnostic Sensitivity for Archimedes Virtual Bronchoscopy Navigation System

System Bronchoscopically Navigated and Accessed Tumors Anywhere in the Lung with Safety, Accuracy and Effectiveness

May 23, 2018

·

3 min read

FDA

Synedgen Receives FDA 510(k) Clearance for Catasyn™ Advanced Technology Wound Hydrogel

FDA clearance for Catasyn provides patients with a new option to treat both minor burns and skin lacerations and physicians with an alternative to treat more severe dermal ulcers, post-operative incision sites and second degree burns.

May 23, 2018

·

3 min read

Genetown

After a Strong Finish to 2017, MEDITECH Continues Progressive Growth in 2018

MEDITECH hit the ground running in 2018, signing both new and current customers to move forward with its state-of-the-art Expanse EHR.

May 23, 2018

·

4 min read

Fujifilm Announces The Expansion Of Its Fill Finish Services To Include Late Phase And Commercial Production Of Gene Therapies And Viral Vaccines To Become An End To End Solutions Provider

FUJIFILM Diosynth Biotechnologies(Fujifilm), has announced the extension of its gene therapy and viral vaccine Fill/Finish.

May 23, 2018

·

3 min read

Business

Sun Pharma Announces USFDA Approval of YONSA® (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone

Sun Pharmaceutical Industries Ltd. and Churchill Pharmaceuticals, LLC. today announced that one of Sun Pharma’s wholly owned subsidiary companies has received approval from the U.S. Food and Drug Administration (FDA) for YONSA® (abiraterone acetate).

May 23, 2018

·

9 min read